Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
Multiple sclerosis (MS) is considered to be a central nervous system (CNS) chronic inflammatory demyelinating disease, affecting more than 2 million individuals worldwide. In this meta-analysis, we aimed to assess the safety and efficacy of autologous mesenchymal stem cells (aMSCs) in treating MS pa...
Saved in:
| Main Authors: | Yang Zhou, Xin Zhang, Hang Xue, Lingling Liu, Jie Zhu, Tao Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2019/8536785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis
by: Jun Yin, et al.
Published: (2025-06-01) -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013-02-01) -
Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2025-03-01) -
Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
by: Ida Erngren, et al.
Published: (2025-07-01) -
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series
by: Alice Mariottini, et al.
Published: (2024-11-01)